Shanghai Henlius Biotech, Inc.
HKEX:2696.HK
23.15 (HKD) • At close September 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 5,394.909 | 3,214.73 | 1,682.472 | 587.586 | 90.929 | 7.421 | 33.91 |
| Cost of Revenue
| 1,476.112 | 844.621 | 522.748 | 182.119 | 71.821 | 5.398 | 15.019 |
| Gross Profit
| 3,918.797 | 2,370.109 | 1,159.724 | 405.467 | 19.108 | 2.023 | 18.891 |
| Gross Profit Ratio
| 0.726 | 0.737 | 0.689 | 0.69 | 0.21 | 0.273 | 0.557 |
| Reseach & Development Expenses
| 1,118.732 | 1,394.514 | 1,023.93 | 894.144 | 607.827 | 365.382 | 257.08 |
| General & Administrative Expenses
| 383.84 | 354.038 | 280.606 | 192.64 | 174.834 | 39.201 | 14.153 |
| Selling & Marketing Expenses
| 1,754.241 | 1,049.292 | 520.261 | 243.648 | 45.689 | 0 | 0 |
| SG&A
| 2,138.081 | 1,403.33 | 800.867 | 436.288 | 220.523 | 39.201 | 14.153 |
| Other Expenses
| -18.126 | -69.043 | -41.896 | -35.393 | -7.448 | 0.064 | -0.41 |
| Operating Expenses
| 3,196.999 | 2,728.801 | 1,782.901 | 1,295.039 | 820.902 | 458.546 | 343.85 |
| Operating Income
| 710.397 | -586.577 | -871.745 | -949.85 | -821.203 | -456.523 | -324.959 |
| Operating Income Ratio
| 0.132 | -0.182 | -0.518 | -1.617 | -9.031 | -61.518 | -9.583 |
| Total Other Income Expenses Net
| -140.819 | -107.31 | -84.994 | -43.691 | -53.607 | -43.697 | -55.038 |
| Income Before Tax
| 569.578 | -693.887 | -956.739 | -993.541 | -874.81 | -500.22 | -379.997 |
| Income Before Tax Ratio
| 0.106 | -0.216 | -0.569 | -1.691 | -9.621 | -67.406 | -11.206 |
| Income Tax Expense
| 23.559 | 1.372 | 27.313 | 43.691 | 0.655 | 4.569 | 4.33 |
| Net Income
| 546.019 | -695.259 | -984.052 | -1,037.232 | -875.465 | -493.686 | -270.562 |
| Net Income Ratio
| 0.101 | -0.216 | -0.585 | -1.765 | -9.628 | -66.526 | -7.979 |
| EPS
| 1.01 | -1.28 | -1.83 | -1.96 | -1.76 | -0.95 | -0.5 |
| EPS Diluted
| 1 | -1.28 | -1.83 | -1.96 | -1.76 | -0.92 | -0.5 |
| EBITDA
| 1,069.63 | -308.974 | -671.569 | -814.074 | -738.704 | -399.356 | -298.254 |
| EBITDA Ratio
| 0.198 | -0.096 | -0.399 | -1.385 | -8.124 | -53.814 | -8.795 |